{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:38:33Z","timestamp":1790890713576,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T00:00:00Z","timestamp":1510099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Women's Dermatology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ijwd.2017.11.004","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T00:02:01Z","timestamp":1515456121000},"page":"49-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Psychosocial impact of inherited and autoimmune blistering diseases"],"prefix":"10.1097","volume":"4","author":[{"given":"Swaranjali V.","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dedee F.","family":"Murrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"10","key":"10.1016\/j.ijwd.2017.11.004_bb0005","first-page":"449","article-title":"Self-esteem of severely burned patients","volume":"61","author":"Bowden","year":"1980","journal-title":"Arch Phys Med Rehabil"},{"issue":"2","key":"10.1016\/j.ijwd.2017.11.004_bb0010","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1111\/ijd.12819","article-title":"Translation, cross-cultural adaptation and validation of the Quality of Life Evaluation in Epidermolysis Bullosa instrument in Brazilian Portuguese","volume":"55","author":"Cestari","year":"2016","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.ijwd.2017.11.004_bb0015","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/1049732311400431","article-title":"The psychosocial impact of epidermolysis bullosa","volume":"21","author":"Dures","year":"2011","journal-title":"Qual Health Res"},{"issue":"2","key":"10.1016\/j.ijwd.2017.11.004_bb0020","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2230.2004.01428.x","article-title":"Assessment of mobility, activities and pain in different subtypes of epidermolysis bullosa","volume":"29","author":"Fine","year":"2004","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2017.11.004_bb0025","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jaad.2013.04.053","article-title":"Measuring quality of life in epidermolysis bullosa in Mexico: cross-cultural validation of the Hispanic version of the Quality of Life in Epidermolysis Bullosa questionnaire","volume":"69","author":"Frew","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.ijwd.2017.11.004_bb0030","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1365-2133.2009.09347.x","article-title":"Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument","volume":"161","author":"Frew","year":"2009","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2017.11.004_bb0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.det.2009.10.019","article-title":"Quality of life measurements in epidermolysis bullosa: tools for clinical research and patient care","volume":"28","author":"Frew","year":"2010","journal-title":"Dermatol Clin"},{"issue":"8","key":"10.1016\/j.ijwd.2017.11.004_bb0040","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2230.2002.01121.x","article-title":"Quality of life in epidermolysis bullosa","volume":"27","author":"Horn","year":"2002","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2017.11.004_bb0045","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5694\/mja11.11549","article-title":"Volunteering at an adventure camp for epidermolysis bullosa","volume":"197","author":"Hwang","year":"2012","journal-title":"Med J Aust"},{"issue":"3","key":"10.1016\/j.ijwd.2017.11.004_bb0050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4088\/PCC.v09n0306","article-title":"Psychodermatology: a guide to understanding common psychocutaneous disorders","volume":"9","author":"Jafferany","year":"2007","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.ijwd.2017.11.004_bb0055","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.advms.2016.07.002","article-title":"Measuring of quality of life in autoimmune blistering disorders in Poland. Validation of disease-specific Autoimmune Bullous Disease Quality of Life (ABQoL) and the Treatment Autoimmune Bullous Disease Quality of Life (TABQoL) questionnaires","volume":"62","author":"Kalinska-Bienias","year":"2017","journal-title":"Adv Med Sci"},{"issue":"4","key":"10.1016\/j.ijwd.2017.11.004_bb0060","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10880-010-9205-4","article-title":"Psychiatric symptoms and quality of life in patients affected by epidermolysis bullosa","volume":"17","author":"Margari","year":"2010","journal-title":"J Clin Psychol Med Settings"},{"issue":"3","key":"10.1016\/j.ijwd.2017.11.004_bb0065","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1468-3083.2010.03780.x","article-title":"Psychological distress and investment in one's appearance in patients with pemphigus","volume":"25","author":"Mazzotti","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.ijwd.2017.11.004_bb0070","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jaad.2008.12.004","article-title":"A ski and adventure camp for young patients with severe forms of epidermolysis bullosa","volume":"61","author":"Nading","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.ijwd.2017.11.004_bb0075","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.clindermatol.2014.02.015","article-title":"Psychologic factors in the development of facial dermatoses","volume":"32","author":"Orion","year":"2014","journal-title":"Clin Dermatol"},{"issue":"2","key":"10.1016\/j.ijwd.2017.11.004_bb0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaad.2008.09.014","article-title":"Quality-of-life assessment in patients with pemphigus using a minimum set of evaluation tools","volume":"60","author":"Paradisi","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.ijwd.2017.11.004_bb0085","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/jpepsy\/26.7.435","article-title":"Review of group interventions for pediatric chronic conditions","volume":"26","author":"Plante","year":"2001","journal-title":"J Pediatr Psychol"},{"issue":"2","key":"10.1016\/j.ijwd.2017.11.004_bb0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2340\/00015555-0376","article-title":"Main problems experienced by children with epidermolysis bullosa: a qualitative study with semi-structured interviews","volume":"88","author":"van Scheppingen","year":"2008","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.ijwd.2017.11.004_bb0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.det.2011.11.008","article-title":"Quality-of-life measurement in blistering diseases","volume":"30","author":"Sebaratnam","year":"2012","journal-title":"Dermatol Clin"},{"issue":"10","key":"10.1016\/j.ijwd.2017.11.004_bb0100","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jamadermatol.2013.4972","article-title":"Development of a quality-of-life instrument for autoimmune bullous disease: the Autoimmune Bullous Disease Quality of Life questionnaire","volume":"149","author":"Sebaratnam","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"9","key":"10.1016\/j.ijwd.2017.11.004_bb0105","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s11136-015-0965-z","article-title":"Reliability of the autoimmune bullous disease quality of life (ABQoL) questionnaire in the USA","volume":"24","author":"Sebaratnam","year":"2015","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.ijwd.2017.11.004_bb0110","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/bjd.12836","article-title":"Burden of disease during quiescent periods in patients with pemphigus","volume":"170","author":"Tabolli","year":"2014","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2017.11.004_bb0115","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1365-2133.2009.09306.x","article-title":"Quality of life in patients with epidermolysis bullosa","volume":"161","author":"Tabolli","year":"2009","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2017.11.004_bb0120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0151-9638(05)79276-0","article-title":"Quality of life and pemphigus","volume":"132","author":"Terrab","year":"2005","journal-title":"Ann Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.ijwd.2017.11.004_bb0125","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/bjd.12623","article-title":"The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease","volume":"69","author":"Tjokrowidjaja","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijwd.2017.11.004_bb0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12955-017-0594-z","article-title":"Reliability and validity of the Chinese version of the autoimmune bullous disease quality of life (ABQoL) questionnaire","volume":"15","author":"Yang","year":"2017","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"10.1016\/j.ijwd.2017.11.004_bb0135","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2340\/00015555-1758","article-title":"Health-related quality of life in epidermolysis bullosa: validation of the Dutch QOLEB questionnaire and assessment in the Dutch population","volume":"94","author":"Yuen","year":"2014","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.ijwd.2017.11.004_bb0140","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijwd.2015.01.002","article-title":"Autoimmune blistering diseases in females: a review","volume":"1","author":"Zhao","year":"2015","journal-title":"Int J Womens Dermatol"}],"container-title":["International Journal of Women's Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647517300953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647517300953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T14:26:44Z","timestamp":1641565604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352647517300953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S2352647517300953"],"URL":"https:\/\/doi.org\/10.1016\/j.ijwd.2017.11.004","relation":{},"ISSN":["2352-6475"],"issn-type":[{"value":"2352-6475","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychosocial impact of inherited and autoimmune blistering diseases","name":"articletitle","label":"Article Title"},{"value":"International Journal of Women's Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijwd.2017.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc. on behalf of Women's Dermatologic Society.","name":"copyright","label":"Copyright"}]}}